Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sales of Olainfarm in May Increase by 19%


Posted on: 20 Jun 17

Olaine, 2017-06-15 19:29 CEST (GLOBE NEWSWIRE) --  

May 2017, consolidated sales Sales, Thsnd. EUR Changes to May, 2016 Share in total sales
Russia 3 389 -11% 31%
Latvia 2 335 35% 22%
Ukraine 1 134 13% 10%
Belarus 879 136% 8%
The Netherlands 839 4214% 8%
Tajikistan 364 162% 3%
Uzbekistan 302 13% 3%
Kazakhstan 284 316% 3%
Germany 157 NA 1%
Lithuania 169 42% 2%
Other 961 -38% 9%
Total 10 813 19% 100%

 

 

Sales of SIA Latvijas Aptieka during May 2017 were 1.7 million euros, which represents an increase by 31% compared to the same period of 2016.  Sixty-five pharmacies were operating during this period. Sales of SIA Silvanols in May 2017 reached 0.38 million, which is an increase by 12% compared to May of 2016.  During May 2017, SIA Silvanols sold its products to eight European countries during this period and with assistance of AS Olainfarm also to Kazakhstan, Lithuania, Russia and Armenia. Sales of SIA Tonus Elast during May 2017 reached 0.55 million euros. The company made its sales in 22 countries in four continents

 

According to preliminary results, consolidated sales of AS Olainfarm in five months reached 49.01 million euros, which represents an increase by 11% compared to five months of 2016.  The biggest sales increase was achieved in The Netherlands, where sales grew by 561%, and Germany, where sales grew by 230%.  Biggest sales reductions took place in Ukraine, where sales shrunk by 40% and Turkmenistan, where sales shrunk by 36%. Major sales markets of the group during May 2017 were Russia, Latvia, Belarus, Ukraine and The Netherlands.

 

 

 

 

5 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 5 months of 2016 Share in total sales
Russia 15 753 20% 32%
Latvia 12 188 16% 25%
Belarus 4 572 12% 9%
Ukraine 4 344 -40% 9%
The Netherlands 3 331 561% 7%
Kazakhstan 988 34% 2%
Italy 825 40% 2%
Lithuania 700 23% 1%
Germany 654 230% 1%
Turkmenistan 590 -36% 1%
Other 5 068 -12% 10%
Total 49 014 11% 100%

 

 

Sales of SIA Latvijas aptieka in five months of 2017 were 8.5 million euros, which represents an increase by 8% compared to the same period of 2016. Sales of SIA Silvanols during this period were 2.45 million euro, which represents an increase by 23% compared to five months of 2016. Products of SIA Silvanols were sold to nine European countries and, with the help of AS Olainfarm also to Lithuania, Russia, Azerbaijan, Belarus and Armenia. Sales of SIA Tonus Elast in five months reached 3.1 million euros, and its products were sold to 33 countries in four continents.

 

According to unconsolidated preliminary results for May 2017, sales of AS Olainfarm during this period reached 9.09 million euros, which represents an increase by 9% compared to the same period of 2016.  The biggest sales increase was achieved in The Netherlands, where sales grew by 4214%.  Sales to Kazakhstan grew by 243%, sales to Tajikistan increased by 150%, but sales to Belarus grew by 136%.  Significant shipments were also made to Germany.  The major sales markets during this period were Russia, Latvia, Ukraine, Belarus and The Netherlands.  During May 2017, products of AS Olainfarm were sold to 28 countries in three continents.

 

May 2017, unconsolidated sales Sales, thsnd. EUR Changes to May, 2016 Share in total sales
Russia 3 234 -15% 36%
Latvia 1 171 8% 13%
Ukraine 1 134 13% 12%
Belarus 879 136% 10%
The Netherlands 839 4214% 9%
Tajikistan 347 150% 4%
Uzbekistan 302 13% 3%
Kazakhstan 235 243% 3%
Germany 154 NA 2%
Lithuania 146 43% 2%
Other 649 -56% 7%
Total 9 090 9% 100%

 

 

According to preliminary unconsolidated numbers, sales of AS Olainfarm in five months of 2017 reached 39.75 million euros, which represents an increase by 3% compared to the same period of 2016. The most rapid sales increase was achieved in The Netherlands, where sales grew by 561% and Germany, where sales grew by 226%.  The biggest sales reduction during this time took place in Ukraine, where sales shrunk by 41%. The major sales markets of As Olainfarm during these five months were Russia, Latvia, Belarus, Ukraine and The Netherlands.  In total during five months of 2017, products of AS Olainfarm were sold to 40 countries in five continents.  

 

 

Five months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to five months of 2016 Share in total sales
Russia 14 436 10% 36%
Latvia 6 034 5% 15%
Belarus 4 521 11% 11%
Ukraine 4 252 -41% 11%
The Netherlands 3 331 561% 8%
Italy 792 35% 2%
Kazakhstan 699 -5% 2%
Germany 646 226% 2%
Turkmenistan 590 -36% 1%
Lithuania 580 19% 1%
Other 3 867 -26% 10%
Total 39 748 3% 100%

 

 

 

General meeting of shareholders of AS Olainfarm held on June1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros.  According to these preliminary sales numbers, in five months of 2017 the company has met 41% of annual target for unconsolidated sales and 39% of annual target for consolidated sales.

 

 

 

 JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

         Information prepared by:
         
         Salvis Lapins
         JSC Olainfarm
         Member of the Management Board
         Rupnicu iela 5, Olaine, Latvia, LV 2114
         Phone: +371 6 7013 717
         Fax: +371 6 7013 777
         E-mail: Salvis.Lapins@olainfarm.lv

GlobeNewswire
globenewswire.com

Last updated on: 14/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.